These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 953955)
21. Phase II study of CCNU (NSC-79037) in the treatment of advanced gastrointestinal cancer. Klaassen DJ; Rapp E Cancer Chemother Rep; 1974; 58(5 Pt 1):667-9. PubMed ID: 4426046 [No Abstract] [Full Text] [Related]
29. Lomustine (CCNU) for the treatment of resistant lymphoma in dogs. Moore AS; London CA; Wood CA; Williams LE; Cotter SM; L'Heureux DA; Frimberger AE J Vet Intern Med; 1999; 13(5):395-8. PubMed ID: 10499719 [TBL] [Abstract][Full Text] [Related]
30. Phase II study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in the treatment of brain tumors. Fewer D; Wilson CB; Boldrey EB; Enot JK Cancer Chemother Rep; 1972 Jun; 56(3):421-7. PubMed ID: 19051504 [TBL] [Abstract][Full Text] [Related]
31. Bleomycin (NSC-125066) and CCNU (NSC-79037) in the combination chemotherapy of mopp-resistant hodgkin's disease. Kurnick JE; White M; Ware DE; Robinson WA Cancer Chemother Rep; 1975; 59(6):1147-50. PubMed ID: 56989 [TBL] [Abstract][Full Text] [Related]
32. [Combination chemotherapy of transplanted rat leukemia L 5222 with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and cyclophosphamide (CPA) as well as with methyl-CCNU and CPA (author's transl)]. Zeller WJ; Berger M Arzneimittelforschung; 1981; 31(2):303-5. PubMed ID: 7194646 [TBL] [Abstract][Full Text] [Related]
33. CCNU (lomustine) toxicity in dogs: a retrospective study (2002-07). Heading KL; Brockley LK; Bennett PF Aust Vet J; 2011 Apr; 89(4):109-16. PubMed ID: 21418164 [TBL] [Abstract][Full Text] [Related]
34. Phase II study of methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer. Engstrom PF; Catalano RB; Creech RH Cancer Treat Rep; 1976 Mar; 60(3):285-7. PubMed ID: 1260784 [No Abstract] [Full Text] [Related]
35. Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer. Douglass HO; Lavin PT; Moertel CG Cancer Treat Rep; 1976 Jun; 60(6):769-80. PubMed ID: 782699 [TBL] [Abstract][Full Text] [Related]
36. Phase II evaluation of 1-(2-chloroethyl)-3-(2,6-dioxo-(piperidyl)-1 nitrosourea (PCNU)(NSC-95466) in patients with advanced carcinoma of the lung. Ratanatharathorn V; Samson MK; Haas CD; Cummings GD; O'Connor EJ; Baker LH Am J Clin Oncol; 1983 Feb; 6(1):99-102. PubMed ID: 6837509 [TBL] [Abstract][Full Text] [Related]
38. Treatment of malignant gliomas and brain metastases in adults with a combination of adriamycin, VM 26, and CCNU. Results of a phase II trail. Pouillart P; Mathe G; Thy TH; Lheritier J; Poisson M; Huguenin P; Gauthier H; Morin P; Parrot R Cancer; 1976 Nov; 38(5):1909-16. PubMed ID: 1033028 [TBL] [Abstract][Full Text] [Related]
39. A phase II study of intravenously- administered methyl CCNU in the treatment of advanced sarcomas. Chang P; Levine MA; Wiernik PH; Walker MD Cancer; 1976 Feb; 37(2):615-9. PubMed ID: 766946 [TBL] [Abstract][Full Text] [Related]
40. [Some preliminary observations on chemotherapy of infantile medulloblastomas with vincristine sulfate and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU)]. Pompili A; Cianfriglia F; Occhipinti E Minerva Pediatr; 1978 Nov; 30(21):1721-4. PubMed ID: 723818 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]